December 4, 2025 – FACIT looks forward to working together with the Ontario Centre of Innovation (OCI) and the consortium of strategic commercialization organizations to expand support for health innovators and start-ups across the province. The MOU brings together key strategic partners in Ontario’s life sciences ecosystem, including adMare BioInnovations, Canadian Centre for Aging & Brain Health Innovation (CABHI), Capital Bioventures, Centre for Commercialization of Regenerative Medicine (CCRM), FACIT, MaRS Discovery District, Ontario Brain Institute (OBI), OBIO®, Ontario Genomics, and Toronto Innovation Acceleration Partners (TIAP) to help accelerate the advancement of health innovations.
“FACIT is proud to join this collaboration to strengthen Ontario’s life sciences ecosystem. With our commercialization venture expertise, partnership with the Ontario Institute for Cancer Research and continuum of risk capital, we’re uniquely positioned to bridge the seed and early venture funding gap, scale oncology start-ups, and create lasting economic and health impact for Ontarians.”
– Peter Goodhand, Acting President of FACIT
Read the full news release here.
PORTFOLIO
FACIT actively manages our diverse portfolio of Ontario oncology assets (including therapeutics, imaging, diagnostics, and technology platforms) that span all stages of commercialization, from proof-of-concept to clinical development.
FUNDS
With critical seed funding, FACIT makes it possible for Ontario’s best cancer research discoveries to compete globally and reach patients.